Aaipharma Inc (1013243) SEC Filing 8-K Material Event for the period ending Friday, January 6, 2006

Aaipharma Inc

CIK: 1013243

View differences made from one to another to evaluate Aaipharma Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aaipharma Inc.


Assess how Aaipharma Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aaipharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2006 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1013243
Form Type: 8-K Corporate News
Accession Number: 0000950144-06-000215
Submitted to the SEC: Wed Jan 11 2006 5:18:42 PM EST
Accepted by the SEC: Wed Jan 11 2006
Period: Friday, January 6, 2006
Industry: Testing Laboratories
  1. Earnings Release
  2. Financial Exhibit
  3. Other Events

External Resources:

Bookmark the Permalink: